It`s a fair point and that`s why I hope we get that deal with Merck Asap. It`s ready to move forward,and Merck`s gonna have to pay if they want that,,no ands ifs or buts. I sure hope you don`t think we should pay for the phase 3 trial with Merck,cause we`re not going to. In the beginning I was all for keeping all the rights for everything,but in hindsight I truly believe that if we had sold off a few like Adro,we`d be fine right now,cash wise,and there`s only so much the company can put on shareholders back,to pay for.Maybe we`ll get the hold lifted for us this week or next,and then we`ll start the NEO,and get some Dough re me from Amgn for it,then we`ll secure a deal with MErck,with upfront cash,and we wait for the EMA and Axal. Once we get close to approval,it`ll be between Merck and Amgn,who`ll try and buy us,and we`ll have most of our rights. Amgn will have NEO and Merck will have the PSA with us. Were you screaming like me,that the NEO should`nt have been given away,because that was a doozy of a give away for our licensing rights.